We are live on ! Find out more
VTRS icon

Viatris

637 hedge funds and large institutions have $20.1B invested in Viatris in 2014 Q1 according to their latest regulatory filings, with 103 funds opening new positions, 178 increasing their positions, 272 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 48

78% more call options, than puts

Call options by funds: $226M | Put options by funds: $126M

16% more funds holding in top 10

Funds holding in top 10: 1922 (+3)

7% more funds holding

Funds holding: 593637 (+44)

10% less capital invested

Capital invested by funds: $22.4B → $20.1B (-$2.33B)

35% less repeat investments, than reductions

Existing positions increased: 178 | Existing positions reduced: 272

Holders
637
Holders Change
+44
Holders Change %
+7.42%
% of All Funds
18.4%
Holding in Top 10
22
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+15.79%
% of All Funds
0.64%
New
103
Increased
178
Reduced
272
Closed
48
Calls
$226M
Puts
$126M
Net Calls
+$99M
Net Calls Change
+$71M
Name Holding Trade Value Shares
Change
Change in
Stake
RFC
101
Russell Frank Company
Washington
$31.7M -$5.21M -107,288 -14%
IC
102
Inverness Counsel
New York
$31M +$5.71M +117,530 +23%
HHC
103
Hutchin Hill Capital
New York
$30.4M +$18.6M +382,300 +159%
RhumbLine Advisers
104
RhumbLine Advisers
Massachusetts
$30.4M -$1.54M -31,733 -5%
State Board of Administration of Florida Retirement System
105
State Board of Administration of Florida Retirement System
Florida
$29.1M -$3.23M -66,445 -10%
HSBC Holdings
106
HSBC Holdings
United Kingdom
$29.1M -$11.6M -238,701 -29%
SCM
107
Stevens Capital Management
Pennsylvania
$28.8M +$17.7M +363,675 +160%
T. Rowe Price Associates
108
T. Rowe Price Associates
Maryland
$28.6M +$481K +9,900 +2%
Barclays
109
Barclays
United Kingdom
$28.1M -$1.54M -31,661 -5%
SCA
110
SAC Capital Advisors
Connecticut
$27M +$1.64M +33,734 +6%
Prudential Financial
111
Prudential Financial
New Jersey
$26.7M +$2.53M +52,200 +11%
NFA
112
Nationwide Fund Advisors
Ohio
$26.4M +$12.4M +254,369 +89%
SG Americas Securities
113
SG Americas Securities
New York
$25.8M -$1.77M -36,544 -6%
MTB
114
Mizuho Trust & Banking
Japan
$25.3M -$617K -12,715 -2%
ALA
115
Atherton Lane Advisers
California
$24.8M -$297K -6,118 -1%
GC
116
Guggenheim Capital
Illinois
$24.6M -$3.48M -71,681 -12%
NTC
117
North Tide Capital
Massachusetts
$24.4M -$31.6M -650,000 -57%
Voloridge Investment Management
118
Voloridge Investment Management
Florida
$23.9M +$23.8M +490,101 New
BJ
119
BlackRock Japan
Japan
$23.5M -$458K -9,429 -2%
PNC Financial Services Group
120
PNC Financial Services Group
Pennsylvania
$23.2M -$1.18M -24,366 -5%
RCAMU
121
Rothschild & Co Asset Management US
Connecticut
$22.8M -$4.26M -87,641 -16%
DIA
122
Dana Investment Advisors
Wisconsin
$22.8M -$582K -11,991 -3%
BSA
123
Braun Stacey Associates
New York
$22.1M -$2.79M -57,510 -11%
CCI
124
Columbus Circle Investors
$21.8M -$24.9M -512,783 -53%
DekaBank Deutsche Girozentrale
125
DekaBank Deutsche Girozentrale
Germany
$21.4M -$464K -9,550 -2%

VTRS Hedge Fund Activity: Q1 2014 in Review

637 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Viatris (VTRS) for Q1 2014, worth a combined $20.1B — down 10% from $22.4B a quarter earlier.

Buyers outnumbered sellers: 103 funds opened new VTRS positions and 48 closed out — a net gain of 55 holders — while 178 added to existing stakes and 272 trimmed.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $474M. The largest seller was Fidelity Investments, cutting an estimated $237M.

  • 637 institutional investors held Viatris (VTRS) as of Q1 2014, up from 593 in Q4 2013.
  • Funds reported $20.1B of Viatris stock for Q1 2014, down 10% quarter-over-quarter.
  • 103 funds opened new Viatris positions in Q1 2014 and 48 closed out, a net change of +55 holders.
  • The largest Viatris buyer in Q1 2014 was BNP Paribas Financial Markets, an estimated $474M added.
  • The largest Viatris seller in Q1 2014 was Fidelity Investments, an estimated $237M sold.

Based on aggregated 13F filings for Q1 2014.